Recursion Pharmaceuticals, Inc. RXRX Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s capital investments accrued but not yet paid?
- Recursion Pharmaceuticals, Inc. (RXRX) reported capital investments accrued but not yet paid of $0 in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s capital investments accrued but not yet paid changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s capital investments accrued but not yet paid decreased by 100.0% year-over-year, from $1.15M to $0.